Uridine triacetate
Uridine triacetate is an orally bioavailable prodrug that rapidly converts to uridine in vivo. It is a research tool used to investigate and mitigate the cardiac and neurological toxicities associated with 5-fluorouracil and capecitabine chemotherapy in both in vitro and animal models.
Product Specifications
CAS Number
4105-38-8
Product Name Alternative
Uridine Triacetate, Uridine, Tri-O-acetyluridine, RG 2133, RG 2133 triacetate, RG 2133 Triacetate, RG2133, RG-2133, RG2133 Triacetate, RG2133 triacetate, RG-2133 Triacetate, PN-401, PN401, PN 401
Field of Research
Pharmacology & Drug Discovery
Purity
99.89% (May vary between batches)
Solubility
DMSO:90 mg/mL (243.04 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (8.91 mM) ; H2O:Insoluble
Smiles
CC (=O) OCC1OC (C (OC (C) =O) C1OC (C) =O) N1C=CC (=O) NC1=O
Molecular Formula
C15H18N2O9
Molecular Weight
370.31
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6420933-01 0.1 mL
HLA-DRA (HLA Class 2 Antigen DRA, Histocompatibility Antigen DR alpha Chain, MLRW, HLA-DRA1) (FITC)
Sign In for Pricing
View Details MBS6420933-02 5x 0.1 mL
HLA-DRA (HLA Class 2 Antigen DRA, Histocompatibility Antigen DR alpha Chain, MLRW, HLA-DRA1) (FITC)
Sign In for Pricing
View Details 